8PR Asia - Market Updates
File
IX BIOPHARMA_KGI INITIATION REPORT_FINAL12Oct2026.pdf · 607 KB · click to show
IX BIOPHARMA_KGI INITIATION REPORT_FINAL12Oct2026.pdf · 607 KB · click to show
KGI on IX BIOPHARMA LTD - EUA & USA Growth Beckons
(We initiate coverage on iX Biopharma with an OUTPERFORM rating and a 12-month target price of S$1.17, based on SOTP, implying 120.8% upside from the S$0.53 last close.)
60 ·